About Us
Zhida Therapeutics is a privately held, university spin-off company dedicated to cutting-edge biomedical research with a vision of providing lifelong cures to patients sufferring serious diseases.
We focus on developing novel biopharmaceutical products for unmet medical needs, with a focus on genetic myopathies such as Duchenne muscular dystrophy. The company is built around our innovation in engineering novel adeno-associated virus and breaking its limit to deliver large therapeutic genes. This innovation allows us to deliver large therapeutic genes to provide maximal protection to the weakened muscle and heart. Learn more about our science and technology. R&D efforts at Zhida Therapeutics focus on providing proof-of-concept support to validate our technology and facilitate partnerships with various established companies in the biomedical field.